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We now have an impressive amount of information 
about several steps in the synthesis of type I collagen 
fibers by skin fibroblasts: (a) the transcription of the 
genes for proal(I) and proa2(I) polypeptide chains; (b) 
the processing of the initial RNA transcripts of the genes 
to mature mRNAs; (c) translation of the mRNAs to pre­
proal(I) and preproa2(I) chains; (d) processing of the 
preproal(I) and preproa2(I) chains to procollagen; and 
(e) the further processing of procollagen to collagen 
fibers. The speed with which we are currently develop­
ing this information about collagen and comparable in­
formation about other constituents of skin suggests that 
skin may well be the first human organ which we fully 
understand. 
As the initial speaker at this conference, I thought it might 
be helpful to set the stage by reviewing the information we now 
have about the question, "How does a fibroblast make type I 
collagen, the most abundant constituent of skin?" (Table). 
The synthesis of any extracellular protein occurs in at least 
6 steps: (a) The structural gene for the protein is "turned on" 
in the sense of being prepared for transcription; (b) the DNA of 
the structural gene is transcribed into an initial RNA transcript; 
(c) the initial RNA transcript is processed by a series of modi­
fications to a mature mRNA; (d) the mRNA is translated into 
a polypeptide chain; (e) the polypeptide chain is processed by 
one or more modifying enzymes; (f) the polypeptide chain folds 
into the correct three-dimensional conformation and is further 
moditied so that its biological activity is expressed. 
In considering the synthesis of type I collagen (for more 
detailed reviews, see references 1-7), we know relatively little 
about the first step, the "turning on" of the structural genes for 
proal (I) and proa2(l) polypeptide chains which comprise the 
molecule. In fact, although we have considerable information 
about regulation of the lac operon and similar gene systems in 
E. coli, we have almost no information about the regulatory 
mechanisms which turn on genes in eukaryotic cells. What we 
know about collagen genes is that most cells, particularly cells 
in culture, either synthesize collagen or contain some of the 
necessary components for collagen synthesis such as active 
prolylhydroxylase [8]. We also know that the gene system for 
collagen synthesis is among the oldest gene systems in the 
multi-cellular organisms, and it dates as far back in evolution 
as the origin of sponges [2]. Therefore, it seems that synthesis 
of extracellular collagen fibers is a major mechanism which 
nature has developed for holding together cells to form a multi­
cellular organism and is an intrinsic property of many cell types. 
We have one further point of information about collagen at the 
level of regulation of the gene in that we know the chromosomal 
location of the proa2(I) chain. The proa2(I) gene was assigned 
to chromosome #7 by use of a cloned cDNA for the human 
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proa2(I) chain [9]. By using a :l2P-Iabeled cloned cDNA and the 
technique known as "Southern blotting," it was Rhown that 
DNA fragments arising from the human proa2(I) gene were 
obtained only from mouse-human cell hybrids and hamster­
human cell hybrids which contained the human chromosome 
#7. 
In the second step, the genes for proal (I) and proa2(I) chains 
are transcribed into RNA. Experiments carried out first with a 
proa2(I) gene from chick embryos [10-12], then with a proa2(I) 
gene from sheep [13] and finally a pro(�2(l) gene from man 
[14,15], demonstrated that both the gene and the initial RNA 
transcript of the collagen gene are about 40,000 bases, or eight 
times longer than the nucleotides necessary to code for the 
protein. The large size of the gene and the initial RNA transcript 
is accounted for by the presence of about 50 separate interven­
ing sequences (Fig 1). Most of the intervening sequences divide 
the central portion of the gene, the part which codes for the a 
chain domain, into short coding sequences or exons of 54 or 108 
bases. The 54 or 108 base exons code for 18 or 36 amino acid 
sequences with the structure (Gly-X-Y)6 or (Gly-X-Yh2 (10-12). 
Occasionally the exons are 49 and 95 bases [12]. These obser­
vations have led to the suggestion that the collagen gene may 
have originated by extensive duplication of a primitive collagen 
of 54 bases [10-12]. Alternatively, it is possible that the large 
number of intervening sequences arose during evolution to 
prevent recombination events (crossover mutations), which fre­
quently occur in highly repetitive DNA sequences. 
In the third step of collagen synthesis, the hnRNAs are 
processed to functional mRNAs. Because there are 50 interven­
ing sequences, over 50 enzymic steps are required. In fact, 
examination of one part of this process has suggested that the 
excision of a single large intervening sequence may occur in 
more than one step [16]. The RNA must also be processed 
through steps that add a "cap" containing 7-methylguanosine 
to its 5' -end, and a stretch of 20-100 adenine nucleotides to the 
:1' -end, much as occurs with most other messengers of eukar­
yotic cells. Recent observations on several types of protein 
mRNAs have indicated that the length of the untranslated 
nucleotides at the 3' -end of the mRNAs for a given protein may 
vary [17]. Therefore, transcription of a single gene can give rise 
to 2 or more different length mRNAs coding for the same 
protein. In the case of type I pro collagen, mRNAs of several 
different sizes have been identified for the proa2(I) chain [15]. 
The significance of this variability in the size of the mRNAs 
coding for a given protein is unclear. 
In the fourth step, the mRNAs are translated into preproal(I) 
and preproa2(I) chains. As appears to be true of all protein 
synthesized for export from cells, the amino terminal ends of the 
newly-synthesized polypeptides contain a stretch of hydropho­
bic amino acids which direct binding of the ribosome to the 
membranes of the rough endoplasmic reticulum. This region of 
the protein, called a "signal sequence" or "pre-sequence," is 
rapidly cleaved after the newly synthesized polypeptide chain 
passes through the membrane of the rough endoplasmic retic­
ulum into the cisternae of the organelle. In the case of collagen 
synthesis, both the proal(I) [18,19] and the proa2(I) [19] chains 
have been shown to have signal peptides, and the signal pep-
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FIG 1. Scheme for the transcription of a gene for a proa chain of 
collagen and processing of the initial RNA transcript to a mature 
mRNA. (Reproduced with permission [26]). 
tides on the proal chain differ in amino acid sequences from 
those of the proa2 chain [19]. 
In the fifth step, as defined here, the preproal(I) and pre­
proa2(l) chains are processed to proa chains by removal of the 
signal peptides, and then the pro a chains are processed into 
triple helical procollagen (Fig 2). The processing of the pro a 
chains involves at least 8 separate enzymes (see references 1 
and 3). 
Three of these enzymes are hydroxylases which synthesize 
the 4-hydroxyproline, 3-hydroxyproline, and hydroxylysine 
found in collagen. Together these enzymes are involved in 
about 120 enzymic reactions in which 100 prolyl residues are 
hydroxylated to hydroxyproline, and about 20 lysyl residues are 
hydroxylated in hydroxylysine. In addition, 2 other enzymes 
add sugars to the hydroxylysyl residues and a separate system 
of enzymes, involving dolichol intermediates, adds sugars to the 
carboxy-terminal propeptide. The processing on the pro a: chain 
also involves association of the chains through the large car­
boxy-terminal propeptides, formation of interchain disulfide 
links among the propeptides, and folding of the three a chain 
domains into the unique, triple-helical conformation found in 
collagen. After these processing steps are completed, the pro­
collagen is secreted. 
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In the sixth step, the secreted procollagen is converted into 
collagen fibers (Fig 3). Here at least 2 separate procollagen 
proteinases are involved [20-25]. One, pro collagen amino-pro­
teinase, removes the amino-propeptides from the 3 proa chains. 
Another pro collagen carboxy-proteinase, removes the carboxy­
propeptides. The amino- and carboxy-propeptides constitute 
about one-third of the pro collagen molecule. With the removal 
of the propeptides, the biological activity of the protein is 
released and the resulting collagen self-assembles into fibers 
[2;3). Finally, in steps not discussed here, the collagen molecules 
which have self-assembled into fibers are cross-linked by a 
series of enzymic and nonenzymatic steps so that large sections 
of the fiber become a single, covalently-linked structure. 
At least 3 important generalizations emerge from this infor­
mation about the synthesis of type I collagen fibers by skin 
fibroblasts. One of these generalizations is that the structural 
and functional relationships of the collagen molecule are re­
markably simple. Each of the 3 a chains contain a large number 
of repeating sequences of -Gly-Pro-Hyp-. These triplets in the 
polypeptide chains direct folding of the chains into the unique 
rope-like, triple-helical conformation which is characteristic of 
the collagen molecule. The remainder of the a chains consist of 
triplets of -Gly-X-Y- in which the side chains of the amino acids 
in the X- and Y-positions point away from the center of the 
triple-helix and thereby provide precisely positioned reactive 
groups that direct lateral and longitudinal assembly of the 
molecules into fibers. The second generalization is that the 
structure of the gene is remarkably complex because of the 
large number of intervening sequences. As indicated above, it 
is not clear as yet whether this complex structure reflects the 
evolution of the gene from a simple 54-base unit or whether it 
reflects an arrangement which is necessary to prevent muta­
tions in the gene. A third generalization is that intracellular 
processing of the protein after the mRN A is translated is 
remarkably complex. There appear to be 2 reasons for this 
complexity. One is that it is probably necessary to tailor the 
hydroxy/proline content of the polypeptide chains so that the 
triple helix is stable but not overly rigid. The second reason for 
the complexity of the processing is probably that the protein 
must be synthesized as a precursor which does not form fibrils 
spontaneously. Otherwise, fibril formation might occur prema­
turely and before the protein is either secreted or before it 
reaches the appropriate extracellular site for self-assembly. 
FIG 2. Scheme for the intracellular biosynthesis of procollagen. He­
produced with permission from the New England Journal of Medicine 
[4]. 
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To date, the final step in the synthesis of collagen fibers has 
been among the most difficult to study. The problems here, 
however, may well be soluble with the development of a new in 
vitro system in which purified pro collagen is treated with a 
mixture of partially purified pro collagen amino- and carboxy­
proteinases [23]. As the propeptides are cleaved from the pro­
tein, the resulting collagen assembles into collagen fibers in a 
controlled manner and under physiological conditions of tem­
perature and pH. When relatively small amounts of enzyme are 
employed in the system, the removal of the pro peptide occurs 
slowly over one or two days. The fibers formed are more regular, 
and five to seven times thicker than any type I collagen fibers 
seen in vivo. In addition, branch points are frequently seen in 
the fibers. Because the components are relatively pure and the 
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conditions for fiber formation are relatively controllable, the 
system appears to provide a means of examining the process of 
fibril formation in considerable detail. 
The large amount of information we now have about the 
processes by which fibroblasts, and other collagen synthesizing 
cells, produce type I collagen fibers has several consequences. 
One is that the information provides a basis with which to 
explore important biological questions such as the factors which 
regulate the growth of development of connective tissues. An­
other consequence is that the information provides a basis for 
determining the molecular basis of a broad range of human 
diseases. As will certainly become apparent at this meeting, 
genetic diseases involving collagen, such as Ehlers-Danlos syn­
drome, have now become the target for highly productive 
research. Acquired diseases involving collagen are still relatively 
intractable. However, the basic information we now have about 
the structure and biosynthesis of collagen, together with ex­
tremely powerful new tools provided by recombinant DNA, 
offer new hope that we will be able to resolve many intriguing 
questions, such as why collagen synthesis is increased in scle­
roderma. 
Finally, it should be noted that the information we have 
about how a skin fibroblast synthesizes type I collagen fibers 
does not stand alone. We are also rapidly developing detailed, 
definitive information about proteoglycans, glycoproteins and 
essentially all the other components of skin. The speed with 
which this information is being acquired suggests, to me at 
least, that skin may well be the first tissue or organ of man 
which we fully understand. 
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